Suggestions

Du même auteur

Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial

Archive ouverte | Garassino, Marina | CCSD

International audience

Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

Archive ouverte | Paik, Paul | CCSD

International audience

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Archive ouverte | Antonia, Scott | CCSD

International audience. BACKGROUND:An earlier analysis in this phase 3 trial showed that durvalumab significantly prolonged progression-free survival, as compared with placebo, among patients with stage III, unresec...

Chargement des enrichissements...